This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

KV Pharma, Silverleaf: Small-Cap Winners

Stocks in this article: KV-ASVLFOPXTOREXCCMESIMGEEE

NEW YORK ( TheStreet) -- Shares of specialty pharma company KV Pharmaceutical (KV-A) were zooming over 150% to $3.85 after U.S. regulators approved its drug, Makena, used to reduce the risk of preterm birth in women with a history of going into labor earlier than 37 weeks. Over 11 million shares were changing hands in afternoon trading.

Shares of timeshare operator Silverleaf (SVLF) soared 70% to $2.44 after hedge fund Cerberus Capital said it would buy the company for $94 million, a 75% premium to its previous day's closing price.

Fremont, California-based Opnext (OPXT) saw its share spurt 30% to $2.62 after it said its losses narrowed in the fiscal third quarter and issued an upbeat forecast for the fourth quarter.

Shares of Orexigen Therapeutics (OREX) were once again attracting buying interest. The stock crashed over 70% earlier this week after regulators rejected its obesity drug. But shares were climbing 17% on Friday to $3.46.

China MediaExpress (CCME) denied a short-seller's allegations of fraud late Thursday. Muddy Waters Research, which has a short position in the stock, had accused the company of engaging in a massive pump and dump scheme. Shares were surging Friday by nearly 20% to $13.50 after plunging by 33% on Thursday.

Shares of Silicon Image (SIMG) jumped 15% to $8.87 after its results and first quarter forecasts beat estimates.

Shares of Evergreen Energy (EEE), Cirrus Logic (CRUS) and video services provider Harmonic (HLIT) were also prominent gainers in the small-cap sector on Friday trading.

-- Written by Shanthi Bharatwaj in New York



>To contact the writer of this article, click here: Shanthi Bharatwaj.

>To follow the writer on Twitter, go to http://twitter.com/shavenk.

>To submit a news tip, send an email to: tips@thestreet.com.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs